July 26, 2024 |

John Clapham is Chief Executive Officer of BioTechnique®, a contract manufacturing organization that specialized in manufacturing highly potent sterile injectable formulations. Headquartered in York, Pennsylvania, BioTechnique® is driving the future of manufacturing innovation in producing essential medicines, including COVID-19 vaccines and boosters. BioTechnique® has the goal of reducing U.S. over-reliance on foreign manufacturers of Active Pharmaceutical Ingredients (APIs) and excipients as well as increasing American advanced manufacturing jobs. BioTechnique® expects to create as many as 250 jobs—many high quality—in the next three years. Mr. Clapham is also the CEO of PSC Biotech®, PSC Software®, and Future Cures. BioTechnique’s parent company, PSC Biotech Corporation, is an international, multidisciplinary consulting firm with American offices around the world. PSC® specializes in engineering, regulatory submissions, commissioning, qualification and validation, compliance, compliance audits and regulatory responses to the Food and Drug Administration (US FDA), European Medicines Agency (EMA) and the Chinese CFDA. PSC Software® is software as a service (SaaS) provider of document control software and enterprise quality management software to ensure compliance with FDA standards on the Life Sciences industry on electronic records, electronic signatures, data security, and the prevention of falsified records. Currently 15 of the 20 largest life sciences companies in the world by revenue utilize PSC Software. Future Cures is a registered 501(c)(3) non-profit agency that is dedicated to finding cures for diseases that are currently incurable. Future Cures distributes grants to academic institutions and sponsors research with a variety of academic researchers. John is a graduate of University of Rhode Island, with a B.S. in Chemical Engineering. He has worked for the United States Department of Defense (Naval Ordnance Station), CPI Plants Inc., Lockwood Greene Engineers, Johnson and Johnson and Fluor Daniel prior to founding PSC Biotech Corporation. John is a former Past President of the Los Angeles Chapter of the International Society of Pharmaceutical Engineers (ISPE). He is also a member of the Parenteral Drug Association (PDA), American Society of Quality (ASQ) and Regulatory Affairs Professionals (RAPS). He is passionate about value creation for his clients in the field of life sciences. John lives in Hummelstown, PA with his spouse and two children. When he is not working, he enjoys spending time with family.